EPO and stroke disorder: Systemically administered EPO has been shown to exert beneficial effects on rabbits subjected to subarachnoid hemorrhage [11] and stroke [12], whereas intranasal administration of recombinant human erythropoietin (rHuEPO) protects rats against focal cerebral ischemia [13].